))
Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 4 of 4)
Archived series ("HTTP Redirect" status)
Replaced by: www.ashp.org
When?
This feed was archived on July 23, 2018 02:23 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 126006684 series 172635
Content provided by ASHP Advantage. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ASHP Advantage or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 4 of 4)
Part 4: Reversal of Target-specific Oral Anticoagulants
Faculty:
Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator
Clinical Professor
The University of Illinois at Chicago College of Pharmacy
Director, Antithrombosis Center
The University of Illinois Hospital and Health Sciences System
Chicago, Illinois
William E. Dager, Pharm.D., BCPS (AQ-Cardiology)
Pharmacist Specialist
UC Davis Medical Center
Sacramento, California
James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)
Senior Manager, Patient Care Services
Department of Pharmacy Services
Henry Ford Hospital
C.E. Credits: This activity is not eligible for continuing education credits.
30 episodes
Share
